Professional Development

Business & Profession Health Economics and Policy

06/05/2023 | Jed Boye | 4 min read

ChatGPT may be the trendy new AI to talk to but how willingly should clinicians be welcoming it into their practices?

Business & Profession Health Economics and Policy

05/29/2023 | Jon Greenaway | 2 min read

The vital importance of global thinking in ophthalmology

Business & Profession Professional Development

05/25/2023 | Imran Rahman | 4 min read

Incorporating technology and increased digitization is key to curbing the UK National Health Service’s crisis

Business & Profession Other

05/24/2023 | Stephen G. Schwartz, Christopher T. Leffler, Andrzej Grzybowski | 3 min read

One-Eyed Warriors: Horatio Nelson

Business & Profession Practice Management

05/23/2023 | Jed Boye | 4 min read

A recent lawsuit involving Dole Veterans Affairs surgeons and Medtronic has rekindled the debate about the place of TOV payments in medicine

Business & Profession Business and Innovation

05/20/2023 | Jed Boye | 3 min read

We take a look back at the highlights and memorable moments of ARVO 2023

Business & Profession Cornea / Ocular Surface

05/17/2023 | Nandini Venkateswaran | 5 min read

Artificial tears - three top tips

Business & Profession Health Economics and Policy

05/11/2023 | Jed Boye | 4 min read

What led to the recent bacterial outbreak in the USA that infected 68 and, resulted in the death of three patients?

Business & Profession Basic & Translational Research

05/09/2023 | Jed Boye, Sarah Healey | 2 min read

Keep up to date with the latest research from ARVO journals through our breakdown

Subspecialties Retina

05/05/2023 | Jed Boye | 4 min read

Is Ozempic’s higher rates of diabetic retinopathy and adverse ocular events compared to other GLP-1 agonists cause for concern?